AARON FRYE: Open Payments
NPI 1083030860 · BEVERLY, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$240 in 13 payments from 5 companies in 2025. Trend: 2023 $152 · 2024 $147 · 2025 $240
Food & beverage: $240
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 5 | $90 |
| Vanda Pharmaceuticals Inc. | 3 | $69 |
| AstraZeneca Pharmaceuticals LP | 3 | $50 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $18 |
| Lilly USA, LLC | 1 | $14 |
Products named: VRAYLAR, HETLIOZ, FANAPT, CAPLYTA, MOUNJARO.
Industry payments across KY — which companies pay providers there.
